Disorders of mineral metabolism, such as hyperphosphatemia, hypocalcemia, and elevated levels of parathyroid hormone (PTH), are often seen in patients with CKD (Fusaro et al., 2021; Wang et al., 2024). The gene discussed is PTH; the disease is Hypocalcemia.